Voyageur Pharmaceuticals has reported successful laboratory results for its Mueller iodine extraction process, achieving 99.8% purity and over 90% recovery. The company is now preparing to deploy a mobile field-capable pilot unit for real-world testing in September 2026.
Voyageur Pharmaceuticals has successfully demonstrated its Mueller iodine extraction process in laboratory settings, achieving 99.8% purity and over 90% recovery from oilfield brine. The company is now preparing to deploy a mobile pilot unit for field testing in September 2026 to validate the process under real-world conditions.
Voyageur Pharmaceuticals has acquired 100% ownership of the 'Mueller Process', a proprietary iodine extraction technology, and appointed its inventor, Dr. Brian Mueller, as Director of Chemistry. Initial bench-scale testing reported a 90% yield from brine to technical grade iodine, though these results have not yet been independently verified.
